Kirkland Represents Jaws Acquisition Corp. on $4.4 billion Merger with Cano Health

Kirkland & Ellis advised Jaws Acquisition Corp. (NYSE: JWS), a special purpose acquisition company, on its proposed merger with Cano Health, LLC, a leading value-based care delivery platform for seniors. The transaction values the combined company at an enterprise value of approximately $4.4 billion. The transaction includes an $800 million concurrent private placement (PIPE) of common stock of the combined company. Upon completion of the transaction, the combined company will operate as Cano Health, LLC, and will be listed on the New York Stock Exchange. The transaction will further accelerate Cano Health’s growth and enable the expansion of its value-based care into new geographies. Barry Sternlicht, Co-Founder and Chairman of Jaws Acquisition Corp. will serve on the Company’s Board of Directors. The transaction is subject to customary closing conditions and is expected to close in the end of the first quarter or the beginning of the second quarter of 2021.

Read the Cano Health and Jaws Acquisition Corp. press release

The Kirkland team was led by transactional partners Michael Brueck and David Perechocky and associate Serena Shi, capital markets partners Christian Nagler and Peter Seligson, tax partners Mike Beinus and Meredith Levy, executive compensation partner Michael Krasnovsky, and real estate partners Scott Berger and Jonathan Schechter.